Literature DB >> 32297847

COVID-19 affects healthy pediatricians more than pediatric patients.

Nima Rezaei1,2,3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32297847      PMCID: PMC7180324          DOI: 10.1017/ice.2020.139

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


× No keyword cloud information.
To the Editor—Coronavirus disease 2019 (COVID-19) emerged in China in late December and has spread rapidly throughout the world. The World Health Organization (WHO) considers it a pandemic. In ~4 months from start of this outbreak, as of April 4, 2020, >1,000,000 patients had been affected.[1] Meanwhile, children appear less likely to be affected than adults; among the affected children, most have mild symptoms and some are even asymptomatic.[2-4] The Chinese Center for Disease Control and Prevention has reported that among ~70,000 cases, <1% were aged <10 years.[5] The first official COVID-19 case in Iran was announced on February 19, 2020. On March 16, 2020, 4 weeks later, the daily situation report on COVID-19 showed that <1% of ~5,000 confirmed cases were children aged <10 years.[6] The Children’s Medical Center in Iran has 348 beds for pediatric patients, with bed occupancy rate of 94.7% and an average length of stay of 3.3 days. During the 4-week period after the first identified case in the country, only 3 positive COVID-19 cases were identified, for an estimated frequency of 1 per 1,000 admitted pediatric patients. Meanwhile, among 60 pediatricians working in this hospital, 5 were positive for COVID-19 by real-time reverse transcription polymerase chain reaction (rRT-PCR), for a prevalence of 8.3%, which was much higher than the frequency of COVID-19 in general population (~2 per 10,000) during this 4-week period. One hypothesis is that aging is a condition associated with inflammation, whereas children might have an immature anti‐inflammatory response. Possibly, therefore, an increased inflammatory reaction is expected in adult subjects compared to children.[7] Not only the pediatricians but also other healthcare professionals are at a higher risk of infection with COVID-19.[8] A report from Italy revealed that ~20% of healthcare professionals had become infected.[9] Healthcare professionals are at the frontline of fighting COVID-19 in hospitals, where they are in contact with visiting patients and their parents who are potentially carriers of SARS-CoV-2, even if they are not infected. Indeed these healthcare professionals are under excessive workload pressure and psychological distress during the pandemic, which can lead to caregiver burnout.[10] Pediatricians, especially those who have children at home, not only have concerns about passing the infection to their children but also about not caring enough for their children during quarantine period, considering school closures and social distancing policies.[8] Therefore, healthcare systems should be very careful to address the physical and mental health of healthcare professionals. Easy access to personal protective equipment, especially for those who are visiting patients with COVID-19, and psychological support for those who are losing their patients and colleagues, especially for those who cannot see their family members for long periods, are necessary.
  8 in total

1.  COVID-19 in Children: Initial Characterization of the Pediatric Disease.

Authors:  Andrea T Cruz; Steven L Zeichner
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

2.  COVID-19: protecting health-care workers.

Authors: 
Journal:  Lancet       Date:  2020-03-21       Impact factor: 79.321

3.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

4.  COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.

Authors:  Bobak Moazzami; Niloofar Razavi-Khorasani; Arash Dooghaie Moghadam; Ermia Farokhi; Nima Rezaei
Journal:  J Clin Virol       Date:  2020-04-04       Impact factor: 3.168

5.  SARS-CoV-2 Infection in Children.

Authors:  Xiaoxia Lu; Liqiong Zhang; Hui Du; Jingjing Zhang; Yuan Y Li; Jingyu Qu; Wenxin Zhang; Youjie Wang; Shuangshuang Bao; Ying Li; Chuansha Wu; Hongxiu Liu; Di Liu; Jianbo Shao; Xuehua Peng; Yonghong Yang; Zhisheng Liu; Yun Xiang; Furong Zhang; Rona M Silva; Kent E Pinkerton; Kunling Shen; Han Xiao; Shunqing Xu; Gary W K Wong
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

Review 6.  Immune-epidemiological parameters of the novel coronavirus - a perspective.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Expert Rev Clin Immunol       Date:  2020-04-06       Impact factor: 4.473

Review 7.  COVID-19 and Italy: what next?

Authors:  Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

8.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  8 in total
  15 in total

Review 1.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

Review 2.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

Review 3.  The urgent need for integrated science to fight COVID-19 pandemic and beyond.

Authors:  Negar Moradian; Hans D Ochs; Constantine Sedikies; Michael R Hamblin; Carlos A Camargo; J Alfredo Martinez; Jacob D Biamonte; Mohammad Abdollahi; Pedro J Torres; Juan J Nieto; Shuji Ogino; John F Seymour; Ajith Abraham; Valentina Cauda; Sudhir Gupta; Seeram Ramakrishna; Frank W Sellke; Armin Sorooshian; A Wallace Hayes; Maria Martinez-Urbistondo; Manoj Gupta; Leila Azadbakht; Ahmad Esmaillzadeh; Roya Kelishadi; Alireza Esteghamati; Zahra Emam-Djomeh; Reza Majdzadeh; Partha Palit; Hamid Badali; Idupulapati Rao; Ali Akbar Saboury; L Jagan Mohan Rao; Hamid Ahmadieh; Ali Montazeri; Gian Paolo Fadini; Daniel Pauly; Sabu Thomas; Ali A Moosavi-Movahed; Asghar Aghamohammadi; Mehrdad Behmanesh; Vafa Rahimi-Movaghar; Saeid Ghavami; Roxana Mehran; Lucina Q Uddin; Matthias Von Herrath; Bahram Mobasher; Nima Rezaei
Journal:  J Transl Med       Date:  2020-05-19       Impact factor: 5.531

Review 4.  Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.

Authors:  Kawthar Mohamed; Niloufar Yazdanpanah; Amene Saghazadeh; Nima Rezaei
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

Review 5.  Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19.

Authors:  Mojdeh Sarzaeim; Nima Rezaei
Journal:  SN Compr Clin Med       Date:  2020-10-06

6.  Clinical and Laboratory Profile of Hospitalized Symptomatic COVID-19 Patients: Case Series Study From the First COVID-19 Center in the UAE.

Authors:  Suad Hannawi; Haifa Hannawi; Kashif Bin Naeem; Noha Mousaad Elemam; Mahmood Y Hachim; Ibrahim Y Hachim; Abdulla Salah Darwish; Issa Al Salmi
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

7.  Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?

Authors:  Fateme Babaha; Nima Rezaei
Journal:  Am J Med Sci       Date:  2020-07-29       Impact factor: 2.378

Review 8.  Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.

Authors:  Arefeh Basiri; Zahra Pazhouhnia; Nima Beheshtizadeh; Mahdieh Hoseinpour; Amene Saghazadeh; Nima Rezaei
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

9.  Genetic predisposition models to COVID-19 infection.

Authors:  Farzaneh Darbeheshti; Nima Rezaei
Journal:  Med Hypotheses       Date:  2020-05-06       Impact factor: 1.538

Review 10.  Microfluidic devices for detection of RNA viruses.

Authors:  Arefeh Basiri; Arash Heidari; Melina Farshbaf Nadi; Mohammad Taha Pahlevan Fallahy; Sasan Salehi Nezamabadi; Mohammadreza Sedighi; Amene Saghazadeh; Nima Rezaei
Journal:  Rev Med Virol       Date:  2020-08-26       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.